https://orcid.org/0000-0002-5347-837X
Figures & data
Figure 1 Schematic illustration of the study workflow.
Table 1 Baseline Characteristics Before Propensity Score Matching of AC and SCC Patients
Table 2 Treatment Before and After Propensity Score Matching of AC and SCC Patients
Figure 2 OS and CSS data of patients with different stages and treatment. The time from randomization to death from any cause, is considered the best therapeutic endpoint in tumor clinical trials when the patient’s survival can be extended. It can intuitively determine whether the treatment method used benefits the patient. The time from randomization to death from the cancer. Reflect the effectiveness of targeted treatment methods on cancer.
Figure 3 The impact of different treatment on OS in patients with different stages of cervical squamous cell carcinoma and cervical adenocarcinoma.
Figure 4 The impact of different treatment on CSS in patients with different stages of cervical squamous cell carcinoma and cervical adenocarcinoma.
Figure 5 OS and CSS data of cervical squamous cell carcinoma and cervical adenocarcinoma in different stages after radiotherapy and chemotherapy.
Table 3 Baseline Characteristics After Propensity Score Matching of SCC Patients
Figure 6 OS and CSS data of patients with different stages and treatment methods after PSM.
Figure 7 The impact of different treatment methods on OS in patients with different stages of cervical squamous cell carcinoma and cervical adenocarcinoma after PSM.
Figure 8 OS and CSS data of different stages of cervical squamous cell carcinoma and cervical adenocarcinoma after radiotherapy and chemotherapy after PSM.
